Nexalin Technology, Inc. (NXL) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Nexalin Technology, Inc. (NXL) closed at USD 2.51 on 2026-10-14, a change of -94.3 % over the past year, with a market capitalization of USD 2.57M.

Nexalin Technology, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Nexalin Technology, Inc. key figures

Previous close

USD 2.51 (2026-10-14)

1-year change

-94.3 %

Market cap

USD 2.57M

Enterprise value

USD 794,679

P/E ratio (trailing)

-0.19

P/E ratio (forward)

-0.33

EPS (trailing)

-12.79

EPS (forward)

-7.55

PEG ratio

n/a

Price to book

1.18

Revenue growth

-82.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.76

Employees

8

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Nexalin Technology, Inc.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Nexalin Technology, Inc. and compare it with other stocks.